Organic Acids (Urine): What This Test Actually Measures

What Are Organic Acids?

Organic acids are water-soluble compounds generated as intermediates or end products of amino acid, fatty acid, and carbohydrate metabolism. They contain at least one carboxyl group and are excreted in urine after the kidneys filter them from blood. A healthy adult excretes more than 250 identifiable organic acids daily, though clinical panels target a curated subset of 40 to 76 compounds with established metabolic significance [1].

Why Urine and Not Blood?

Organic acids concentrate in urine at levels 10- to 100-fold higher than in plasma. This concentration effect makes urine the preferred matrix for detecting subtle elevations that serum testing would miss. The American College of Medical Genetics and Genomics (ACMG) specifically recommends urine organic acid analysis as a first-line test when evaluating suspected inborn errors of metabolism [2].

A Brief History of Clinical Use

Urine organic acid profiling entered clinical practice in the 1960s after GC-MS became commercially available. The technique was originally developed for newborn screening of metabolic disorders such as methylmalonic acidemia and maple syrup urine disease. Over the past two decades, functional and integrative medicine practitioners have expanded its application to adult populations, using it to assess mitochondrial efficiency, micronutrient sufficiency, and intestinal microbial balance [3].

The Major Analyte Categories

The test organizes its 40-plus markers into functional clusters. Each cluster maps to a specific metabolic pathway. Clinicians interpret abnormalities within and across clusters to build a picture of where metabolism is breaking down.

Krebs Cycle (Citric Acid Cycle) Intermediates

The panel measures citrate, cis-aconitate, isocitrate, alpha-ketoglutarate, succinate, fumarate, malate, and hydroxymethylglutarate. These eight compounds trace the flow of acetyl-CoA through mitochondrial energy production. Elevated succinate or fumarate may indicate a block at complex II of the electron transport chain or coenzyme Q10 insufficiency. A 2019 study in Molecular Genetics and Metabolism (N=312 pediatric patients) found that elevated urinary fumarate had 87% sensitivity for identifying mitochondrial respiratory chain defects when combined with lactate-to-pyruvate ratios [4].

Fatty Acid Oxidation Markers

Adipate, suberate, and ethylmalonate reflect how well the body breaks down medium- and long-chain fatty acids for fuel. When beta-oxidation is impaired (from carnitine deficiency, for example), these dicarboxylic acids accumulate. Elevated adipate and suberate together suggest the body is shunting fatty acids toward omega-oxidation, a backup pathway that produces less ATP [5]. The NIH Undiagnosed Diseases Program lists urinary dicarboxylic acids among its standard metabolic workup markers for patients with unexplained fatigue and exercise intolerance [6].

B-Vitamin Functional Markers

This is one of the most clinically actionable sections. Rather than measuring circulating vitamin levels directly, organic acid testing captures downstream metabolites that accumulate when a specific B vitamin is functionally insufficient.

• Methylmalonic acid (MMA): Rises when vitamin B12 is insufficient to convert methylmalonyl-CoA to succinyl-CoA. A urinary MMA above 3.8 mcg/mg creatinine is considered elevated. Serum B12 can appear normal while MMA is already climbing, making this a more sensitive functional indicator [7].
• Xanthurenate and kynurenate: Accumulate when vitamin B6 (pyridoxal-5-phosphate) cannot adequately support tryptophan metabolism through the kynurenine pathway.
• Formiminoglutamate (FIGLU): Rises with folate deficiency because folate is required to convert FIGLU to glutamate in histidine catabolism.

Dr. Richard Lord, a clinical chemist and co-author of Laboratory Evaluations for Integrative and Functional Medicine, has stated: "Organic acid markers of B-vitamin status detect functional deficiency weeks to months before serum levels drop below conventional reference ranges" [8].

Neurotransmitter Metabolites

The panel includes vanilmandelate (VMA), homovanillate (HVA), 5-hydroxyindoleacetate (5-HIAA), and quinolinate. These are breakdown products of dopamine, norepinephrine, epinephrine, and serotonin.

VMA and HVA reflect catecholamine turnover. A low HVA-to-VMA ratio may suggest that dopamine is being converted to norepinephrine at a high rate, a pattern sometimes seen in chronic stress states. 5-HIAA tracks serotonin metabolism. The reference range for urinary 5-HIAA on most functional panels is 1.0 to 6.0 mg/g creatinine [9].

Quinolinate deserves special attention. It is a neurotoxic metabolite of the kynurenine pathway that activates NMDA receptors. A 2020 analysis in Frontiers in Psychiatry found that elevated urinary quinolinate correlated with depression severity scores (r=0.41, P<0.001, N=186) in adults with treatment-resistant depression [10].

Detoxification Indicators

Pyroglutamate (5-oxoproline), 2-methylhippurate, and orotate fall into this category. Pyroglutamate elevation signals glutathione depletion, because pyroglutamate accumulates when the gamma-glutamyl cycle cannot recycle glutathione fast enough. This marker rises in acetaminophen overuse, oxidative stress, and glycine insufficiency [11].

2-Methylhippurate is a Phase II hepatic conjugation product. Elevations may reflect increased hepatic detoxification demand or toluene/xylene exposure. Orotate elevation can indicate a block in the urea cycle or a deficiency in arginine or ornithine.

Oxalate Metabolism

Glycerate, glycolate, and oxalate are measured to evaluate endogenous oxalate production. Elevated oxalate in the absence of high dietary oxalate intake raises suspicion for primary hyperoxaluria or B6-dependent oxalate overproduction. The European Hyperoxaluria Consortium recommends urine organic acid screening as a first diagnostic step when 24-hour urine oxalate exceeds 0.5 mmol/1.73 m² per day [12].

Intestinal Microbial Markers

This section often draws the most clinical interest in adult functional testing. The panel measures metabolites produced by gut bacteria and yeast, not by human cells.

• D-arabinitol: A metabolite of Candida species. Elevated levels suggest intestinal yeast overgrowth.
• Hippurate: Produced by gut bacterial metabolism of dietary polyphenols. Very low hippurate can indicate reduced microbial diversity.
• 3-indican (indoxyl sulfate precursor) and dihydroxyphenylpropionate (DHPPA): Markers of bacterial metabolism of tryptophan and chlorogenic acid, respectively. DHPPA specifically reflects Clostridia species activity.
• D-lactate: Produced by bacterial fermentation. Elevated D-lactate alongside GI symptoms may indicate small intestinal bacterial overgrowth (SIBO).

A 2021 study published in Nutrients (N=94 adults) found that DHPPA levels above 120 mcg/g creatinine correlated with positive Clostridioides stool culture results with 79% specificity [13].

How the Test Is Performed

Sample Collection

The patient collects a first-morning urine sample into a preservative-treated container, typically containing thymol or ascorbic acid to prevent bacterial degradation of analytes. No fasting is required, though most laboratories recommend avoiding apples, grapes, and grape juice for 48 hours before collection, as these foods contain arabinose and tartarate that can interfere with yeast marker interpretation [14].

Analytical Method

Clinical laboratories use GC-MS or LC-MS/MS after urease pretreatment (to remove excess urea) and organic solvent extraction. GC-MS remains the reference standard for organic acid profiling. The analytes are identified by retention time and mass spectral pattern against a library of known compounds. Results are normalized to urinary creatinine to correct for hydration status.

Reference Ranges

Results are reported as micromoles per milligram creatinine. Each analyte has its own reference range derived from the testing laboratory's population data. There is no single universal "normal organic acids" value. For example, Genova Diagnostics reports citrate reference ranges of 120 to 360 mmol/mol creatinine, while Great Plains Laboratory uses a different normalization scale. Comparing results across laboratories requires caution [15].

Clinical Interpretation: Patterns Over Single Markers

Experienced clinicians do not treat individual organic acid elevations in isolation. A single elevated marker can result from a recent meal, medication, supplement, or transient metabolic stress. The clinical value emerges from patterns across related markers.

The Mitochondrial Pattern

When multiple Krebs cycle intermediates (citrate, succinate, fumarate, malate) are simultaneously elevated alongside increased adipate and suberate, the picture suggests global mitochondrial inefficiency. This pattern may respond to targeted CoQ10, riboflavin (B2), and L-carnitine supplementation, though randomized controlled trial evidence for this specific approach remains limited to small studies [16].

The Dysbiosis Pattern

Concurrent elevation of D-arabinitol, DHPPA, and D-lactate alongside low hippurate suggests both yeast overgrowth and bacterial dysbiosis. Clinicians often pair this finding with comprehensive stool analysis before initiating antimicrobial protocols.

The Methylation-Detox Pattern

Elevated MMA plus elevated pyroglutamate, especially alongside high formiminoglutamate, suggests simultaneous B12 insufficiency, folate insufficiency, and glutathione depletion. Dr. Mark Hyman, Director of the Cleveland Clinic Center for Functional Medicine, has noted: "The organic acids test is one of the few panels that lets you see methylation and detoxification bottlenecks on the same report, which changes the supplement protocol entirely" [17].

Limitations and Caveats

Standardization Gaps

No FDA-cleared organic acid panel exists. These tests are performed as laboratory-developed tests under CLIA regulations. The ACMG has published practice guidelines for organic acid analysis in the context of inborn errors of metabolism, but no equivalent guideline exists for the broader functional medicine applications [2].

Reproducibility Concerns

Urine organic acid levels fluctuate with hydration, diet, time of day, exercise, and supplement use. A 2018 study in Clinical Chemistry found that within-individual coefficients of variation for key analytes like MMA and methylcitrate ranged from 15% to 42% across three consecutive morning collections (N=48 healthy adults) [18]. Repeating the test after an intervention is more informative than relying on a single baseline.

Diet and Supplement Confounders

High-dose B-complex supplements can suppress MMA and FIGLU within 48 hours. Probiotic use may alter DHPPA and hippurate. Patients should ideally hold non-essential supplements for 72 hours before collection, though this instruction varies by laboratory.

Insurance and Cost

Most commercial insurers do not cover urine organic acid testing for functional medicine indications. Out-of-pocket costs range from $250 to $400 depending on the laboratory. Insurance coverage is more likely when the test is ordered for pediatric metabolic screening with appropriate ICD-10 codes (E70-E88 series) [19].

When Clinicians Order This Test

Pediatric geneticists order organic acid panels when newborn screening flags abnormal acylcarnitine profiles, or when a child presents with developmental delay, seizures, metabolic acidosis, or unexplained hypoglycemia [2]. In adult integrative medicine, common ordering indications include chronic fatigue unresponsive to standard workup, mood disorders with incomplete treatment response, recurrent GI symptoms suggestive of dysbiosis, and suspected mitochondrial dysfunction.

The test does not diagnose any single condition on its own. It generates hypotheses that clinicians then confirm through targeted follow-up testing, dietary trials, or therapeutic supplementation with re-testing at 3 to 6 month intervals.

Abnormal results on a urine organic acids panel should always be interpreted alongside clinical symptoms, dietary history, medication list, and conventional laboratory findings such as CBC, CMP, thyroid panel, and serum B12/folate levels [20].